Notable Labs Ltd Asset Turnover Ratio (NTBL), as of second quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Notable Labs Ltd   (NASDAQ: NTBL)
 

Notable Labs Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Notable Labs Ltd 's asset turnover ratio has remained unchanged compare to previous quarter at 0.01 in the second quarter (Jun 30 2024)

Within sector Notable Labs Ltd achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2024 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NTBL Asset Turnover Ratio (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Asset Change -59.19 % -53.5 % 263.85 % -39.02 % -41.04 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.01 0.01 0.01 - -
NTBL's Total Ranking # # # # #
Seq. Asset Change -23.42 % -87.28 % 391.36 % -14.7 % -12.74 %
Seq. Revenue Change 100 % -99.68 % - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




NTBL Company Profile • Back to NTBL Efficiency Comparisons • Compare NTBL Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2024 Assets at quarter ending Jun 30 2024
Biocorrx Inc   0.09 $ 0.037  Millions$ 0.430  Millions
Dbv Technologies S a   0.08 $ 13.814  Millions$ 165.899  Millions
Arbutus Biopharma Corp  0.08 $ 10.061  Millions$ 122.391  Millions
Sangamo Therapeutics Inc   0.08 $ 12.277  Millions$ 151.748  Millions
Caribou Biosciences Inc   0.08 $ 33.113  Millions$ 417.373  Millions
2seventy Bio Inc   0.08 $ 44.120  Millions$ 558.795  Millions
C4 Therapeutics Inc   0.08 $ 29.378  Millions$ 372.232  Millions
Igc Pharma Inc   0.08 $ 1.062  Millions$ 13.545  Millions
Arvinas Inc   0.08 $ 93.300  Millions$ 1,213.775  Millions
Scynexis Inc   0.08 $ 9.666  Millions$ 125.755  Millions
Solana Company  0.08 $ 0.594  Millions$ 7.787  Millions
Recursion Pharmaceuticals Inc   0.08 $ 49.635  Millions$ 654.558  Millions
Xoma Royalty Corporation  0.07 $ 15.239  Millions$ 205.274  Millions
Bolt Biotherapeutics Inc   0.07 $ 11.166  Millions$ 150.552  Millions
Taysha Gene Therapies Inc   0.07 $ 12.873  Millions$ 180.473  Millions
60 Degrees Pharmaceuticals Inc   0.07 $ 0.408  Millions$ 5.788  Millions
Vystar Corporation  0.07 $ 0.156  Millions$ 2.212  Millions
Anaptysbio Inc   0.07 $ 30.473  Millions$ 443.232  Millions
Aligos Therapeutics Inc   0.07 $ 7.967  Millions$ 118.523  Millions
Lexaria Bioscience Corp   0.07 $ 0.377  Millions$ 5.635  Millions
Keros Therapeutics Inc   0.06 $ 26.210  Millions$ 409.278  Millions
Stoke Therapeutics Inc   0.06 $ 15.156  Millions$ 245.293  Millions
Merus N v   0.06 $ 35.193  Millions$ 584.498  Millions
Omniab Inc   0.06 $ 21.714  Millions$ 364.188  Millions
Lineage Cell Therapeutics Inc   0.06 $ 6.186  Millions$ 104.614  Millions
Northwest Biotherapeutics Inc  0.06 $ 1.645  Millions$ 29.037  Millions
Harvard Apparatus Regenerative Technology Inc   0.06 $ 0.216  Millions$ 3.820  Millions
Bicycle Therapeutics Plc  0.06 $ 39.574  Millions$ 709.631  Millions
Oncternal Therapeutics Inc   0.06 $ 1.846  Millions$ 33.231  Millions
Werewolf Therapeutics Inc   0.05 $ 9.283  Millions$ 170.630  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.